DHS 115.01 HistoryHistory: Cr. Register, May, 1993, No. 449, eff. 6-1-93; correction made under s. 13.93 (2m) (b) 7., Stats., Register, July, 1995, No. 475; CR 14-074: am. Register July 2015 No. 715, eff. 8-1-15; EmR1920: emerg. am., eff. 10-15-19; CR 19-064: am Register December 2019 No. 768, eff. 1-1-20. DHS 115.02DHS 115.02 Applicability. This chapter applies to the attending physician licensed under ch. 448, Stats., nurse-midwife certified under s. 441.15, Stats., or other attendant at the birth of an infant born in Wisconsin, to the infant and the infant’s parents or guardian, and to the state laboratory. DHS 115.02 HistoryHistory: Cr. Register, May, 1993, No. 449, eff. 6-1-93; CR 14-074: am. Register July 2015 No. 715, eff. 8-1-15. DHS 115.03DHS 115.03 Definitions. In this chapter: DHS 115.03(1)(1) “Congenital disorder” means a disorder present at birth, either inherited or due to an influence occurring during gestation up to birth. DHS 115.03(2)(2) “Department” means the Wisconsin department of health services. DHS 115.03(3)(3) “ICD-10-CM” means the International Classification of Diseases, 10th Revision, Clinical Modification. DHS 115.03(4)(4) “Medical consultant” means a physician licensed to practice medicine or osteopathy under ch. 448, Stats., who has expertise in treatment of one or more of the conditions listed under s. DHS 115.04. DHS 115.03(5)(5) “Metabolic disorder” means a disorder of the chemical processes that take place in the body. DHS 115.03(6)(6) “Screening” means checking each member of a population to identify presumptive medical conditions that indicate that diagnostic testing for congenital or metabolic disorders is needed. DHS 115.03 HistoryHistory: Cr. Register, May, 1993, No. 449, eff. 6-1-93; correction in (2) made under s. 13.92 (4) (b) 6., Stats., Register January 2009 No. 637; CR 14-074: am. (3) Register July 2015 No. 715, eff. 10-1-15. DHS 115.04DHS 115.04 Congenital disorders. Pursuant to s. 253.13 (1), Stats., blood samples taken from each newborn shall be tested for all of the following conditions: DHS 115.04(4)(4) Hemoglobinopathies, including all of the following: DHS 115.04(6)(6) Congenital adrenal hyperplasia, ICD-10-CM-E25.0. DHS 115.04(8)(8) Fatty acid oxidation disorders, including all of the following: DHS 115.04(8)(a)(a) Medium-chain acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.311. DHS 115.04(8)(b)(b) Long-chain L-3-Hydroxy acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.318. DHS 115.04(8)(c)(c) Very long-chain acyl-CoA dehydrogenase deficiency, ICD-10-CM-E71.310. DHS 115.04(8)(cm)(cm) Carnitine palmitoyltransferase IA deficiency, ICD-10-CM-E71.318. DHS 115.04(8)(d)(d) Carnitine palmitoyltransferase II deficiency, ICD-10-CM-E71.318. DHS 115.04(8)(e)(e) Carnitine-acylcarnitine translocase deficiency, ICD-10-CM-E71.318. DHS 115.04(8)(i)(i) Medium/short-chain hydroxy CoA dehydrogenase deficiency, ICD-10-CM-E71.318. DHS 115.04(8)(j)(j) Medium-chain ketoacyl-CoA thiolase deficiency, ICD-10-CM-E71.318. DHS 115.04(11)(11) Tyrosinemia types I, II, and III, ICD-10-CM-E70.21. DHS 115.04(14)(14) Severe Combined Immunodeficiency and related conditions of immunodeficiency, ICD-10-CM-D81.9. DHS 115.04(15)(c)(c) Methylmalonic acidemia (CBL A, B, C, D; MUT), ICD-10-CM-E71.120. DHS 115.04(16)(16) Critical congenital heart disease, including all of the following: DHS 115.04(16)(g)(g) Single ventricle heart disease variants other than HLHS, including all of the following: DHS 115.04(16)(g)3.3. Congenital malformations of the tricuspid valve unspecified, ICD-10-CM-Q22.9.
/exec_review/admin_code/dhs/110/115
true
administrativecode
/exec_review/admin_code/dhs/110/115/04/8/c
Department of Health Services (DHS)
Chs. DHS 110-199; Health
administrativecode/DHS 115.04(8)(c)
administrativecode/DHS 115.04(8)(c)
section
true